Sanuwave Health Appoints Greg Bazar to Board of Directors
Sanuwave Health (NASDAQ:SNWV) has appointed Greg Bazar to its Board of Directors. Bazar brings extensive experience in engineering, computer science, cybersecurity, AI, and business intelligence. He currently serves as Chairman of Simpatico Systems and was previously instrumental at 3D-P, leading to its acquisition by Epiroc. The appointment comes as board member Michael Stolarski steps down, though he will remain as a consultant to assist with the transition.
Bazar's appointment aligns with Sanuwave's focus on interdisciplinary leadership and its evolution beyond therapeutics into informational ecosystems. His background in technology and cybersecurity is expected to contribute to the company's future roadmap in wound care solutions.
Sanuwave Health (NASDAQ:SNWV) ha nominato Greg Bazar nel suo Consiglio di Amministrazione. Bazar porta con sé una vasta esperienza in ingegneria, informatica, cybersecurity, intelligenza artificiale e business intelligence. Attualmente è Presidente di Simpatico Systems e in passato ha avuto un ruolo chiave in 3D-P, contribuendo alla sua acquisizione da parte di Epiroc. La nomina arriva mentre il membro del consiglio Michael Stolarski si ritira, pur rimanendo consulente per facilitare la transizione.
La nomina di Bazar si allinea con l'attenzione di Sanuwave verso una leadership interdisciplinare e la sua evoluzione oltre la terapia verso ecosistemi informativi. Il suo background in tecnologia e cybersecurity è destinato a supportare il futuro sviluppo dell'azienda nelle soluzioni per la cura delle ferite.
Sanuwave Health (NASDAQ:SNWV) ha nombrado a Greg Bazar en su Junta Directiva. Bazar aporta una amplia experiencia en ingeniería, informática, ciberseguridad, inteligencia artificial y business intelligence. Actualmente es presidente de Simpatico Systems y anteriormente fue clave en 3D-P, lo que llevó a su adquisición por parte de Epiroc. Este nombramiento se produce cuando el miembro de la junta Michael Stolarski se retira, aunque permanecerá como consultor para ayudar en la transición.
La incorporación de Bazar está alineada con el enfoque de Sanuwave en un liderazgo interdisciplinario y su evolución más allá de la terapia hacia ecosistemas informativos. Se espera que su experiencia en tecnología y ciberseguridad contribuya a la hoja de ruta futura de la compañía en soluciones para el cuidado de heridas.
Sanuwave Health (NASDAQ:SNWV)는 Greg Bazar를 이사회 멤버로 임명했습니다. Bazar는 공학, 컴퓨터 과학, 사이버 보안, 인공지능, 비즈니스 인텔리전스 분야에서 풍부한 경험을 보유하고 있습니다. 현재 Simpatico Systems의 회장을 맡고 있으며, 이전에는 3D-P에서 핵심 역할을 하여 Epiroc에 인수되는 데 기여했습니다. 이번 임명은 이사회 멤버인 Michael Stolarski가 물러나면서 이루어졌으며, 그는 전환 과정을 돕기 위해 컨설턴트로 남아 있습니다.
Bazar의 임명은 Sanuwave가 치료제를 넘어 정보 생태계로 진화하는 다학제적 리더십에 중점을 둔 전략과 일치합니다. 그의 기술 및 사이버 보안 배경은 상처 치료 솔루션 분야에서 회사의 미래 로드맵에 기여할 것으로 예상됩니다.
Sanuwave Health (NASDAQ:SNWV) a nommé Greg Bazar au sein de son conseil d'administration. Bazar apporte une vaste expérience en ingénierie, informatique, cybersécurité, intelligence artificielle et business intelligence. Il est actuellement président de Simpatico Systems et a précédemment joué un rôle clé chez 3D-P, contribuant à son acquisition par Epiroc. Cette nomination intervient alors que Michael Stolarski, membre du conseil, se retire, tout en restant consultant pour faciliter la transition.
La nomination de Bazar s'inscrit dans la volonté de Sanuwave de privilégier un leadership interdisciplinaire et d'évoluer au-delà des thérapies vers des écosystèmes informationnels. Son expertise en technologie et cybersécurité devrait soutenir la feuille de route future de l'entreprise dans les solutions de soins des plaies.
Sanuwave Health (NASDAQ:SNWV) hat Greg Bazar in seinen Vorstand berufen. Bazar bringt umfangreiche Erfahrung in den Bereichen Ingenieurwesen, Informatik, Cybersicherheit, KI und Business Intelligence mit. Er ist derzeit Vorsitzender von Simpatico Systems und war zuvor maßgeblich bei 3D-P tätig, was zur Übernahme durch Epiroc führte. Die Ernennung erfolgt, während das Vorstandsmitglied Michael Stolarski zurücktritt, der jedoch als Berater für die Übergangsphase erhalten bleibt.
Bazars Ernennung passt zur Ausrichtung von Sanuwave auf interdisziplinäre Führung und die Weiterentwicklung von therapeutischen Lösungen hin zu Informationsökosystemen. Sein Hintergrund in Technologie und Cybersicherheit soll zur zukünftigen Strategie des Unternehmens im Bereich Wundversorgung beitragen.
- None.
- None.
Bazar brings decades of experience in engineering, computer science and cyber security, AI, and business intelligence over a career of building successful companies
EDEN PRAIRIE, Minn., May 28, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (Nasdaq:SNWV), a leading provider of next-generation FDA-approved wound care products, is pleased to announce the addition of Greg Bazar to its Board of Directors.
Bazar brings decades of leadership experience in engineering, technology, and cybersecurity to Sanuwave’s Board of Directors. He currently serves as Chairman of the Board at Simpatico Systems, a company he founded to deliver advanced IT and cybersecurity solutions. Previously, he was the first employee at intelligent connectivity provider 3D-P, where he played a pivotal role in the company’s growth and strategic direction, ultimately becoming Chairman of the Board and leading it through its acquisition by Epiroc, a global leader in mining and infrastructure solutions. Greg began his career at Caterpillar, gaining global experience in leveraging technology to enhance human innovation. He holds a degree in engineering from the Colorado School of Mines.
“All of the interesting parts of the future are interdisciplinary; this is why Sanuwave focuses on finding drivers and leaders with unusual Venn overlaps in their experience and talents. Greg fits this mold, bringing expertise in a variety of disciplines that will be important to our future roadmap as well as a proven track record of the culture building that makes for successful companies,” said Sanuwave CEO Morgan Frank. “He’s ‘one of us’ and we look forward to working with him on our mission to revolutionize complex wound care.”
"From engineering to cybersecurity, I’ve always been drawn to smart solutions. Sanuwave’s healing technology is brilliant, and as it evolves beyond therapeutics and into informational ecosystems, this is clearly the way forward. Let’s make some noise—and some progress!"
Greg joined the Sanuwave board on May 27, 2025.
The Company also announced that long-time board member Michael Stolarski will be stepping down in order to spend more (much needed) time with his golf game and eating fancy things.
“Mike has been a Sanuwave stalwart since the early days, and we thank him for his inestimable contributions and good humor over the years,” said Morgan Frank. “We’ll miss ya, buddy.”
Mr Stolarski has agreed to remain a consultant to the Company to provide continuity and to assist in the transition.
About Sanuwave
Sanuwave Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures.
Sanuwave’s end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the body’s normal healing processes. Sanuwave applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions.
Forward-Looking Statements
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to future financial results, production expectations, plans for future business development activities and expectations regarding the impact of changes in tariff rates. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are risks associated with regulatory oversight, the Company’s ability to manage its capital resources, competition and the other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement.
Contact: investors@sanuwave.com
FAQ
Who is Greg Bazar and why did Sanuwave Health (SNWV) appoint him to the board?
What experience does Greg Bazar bring to Sanuwave Health's board?
Who is leaving Sanuwave Health's board of directors?
What is Sanuwave Health's (SNWV) business focus?
